Guardian Bio Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 10

Guardian Bio General Information

Description

Operator of a biotech company intended to offer a product that drives anti-tumor activity by eliciting a diverse and targeted immune response. The company takes stem cells from patients turns them into cancer-targeted dendritic cells and injects them back into patients to revitalize their immune systems, enabling cancer patients to get access to suitable treatment for cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Boston, MA
  • United States
Primary Industry
Biotechnology
Corporate Office
  • Boston, MA
  • United States

Guardian Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Guardian Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 12-Jul-2023 Completed Generating Revenue
4. Seed Round 08-Sep-2022 Completed Generating Revenue
3. Accelerator/Incubator 26-Jul-2022 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Guardian Bio’s complete valuation and funding history, request access »

Guardian Bio Patents

Guardian Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025076176-A2 Cross-presenting dendritic cells Inactive 04-Oct-2023
WO-2025076176-A3 Cross-presenting dendritic cells Inactive 04-Oct-2023

Guardian Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Guardian Bio Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Creative Destruction Lab Accelerator/Incubator
Angel (individual) Minority
Brazen Capital Venture Capital Minority
Fundament Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 10 investors. Get the full list »

Guardian Bio FAQs

  • When was Guardian Bio founded?

    Guardian Bio was founded in 2022.

  • Where is Guardian Bio headquartered?

    Guardian Bio is headquartered in Boston, MA.

  • What is the size of Guardian Bio?

    Guardian Bio has 3 total employees.

  • What industry is Guardian Bio in?

    Guardian Bio’s primary industry is Biotechnology.

  • Is Guardian Bio a private or public company?

    Guardian Bio is a Private company.

  • What is Guardian Bio’s current revenue?

    The current revenue for Guardian Bio is .

  • How much funding has Guardian Bio raised over time?

    Guardian Bio has raised $500K.

  • Who are Guardian Bio’s investors?

    Creative Destruction Lab, , Brazen Capital, Fundament, and are 5 of 10 investors who have invested in Guardian Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process